Carpal Tunnel And Body Pain Articles

Voltaren® Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated With Osteoarthritis

Parsippany, NJ (PRWEB) October 23, 2007 -- Voltaren® Gel (http://www.voltarengel.com) (diclofenac sodium topical gel) 1% has received US regulatory approval as the first topical prescription treatment that patients can apply directly to sites of pain associated with osteoarthritis.

The US Food and Drug Administration (FDA) granted the approval to Novartis for Voltaren Gel, which is a non-steroidal anti-inflammatory (NSAID) medication, for use in treating pain associated with osteoarthritis in joints amenable to topical treatment, such as the knees and those of the hands.

Osteoarthritis is a chronic condition characterized by the breakdown of cartilage in the joint.

Clinical trials have demonstrated Voltaren Gel to be highly effective in treating osteoarthritis pain in the hands and knees, which are the body's most commonly affected joints. It is the first prescription topical osteoarthritis treatment to have proven its effectiveness in both the knees and joints of the hands through clinical trials. Voltaren Gel delivers effective pain relief with a favorable safety profile as its systemic absorption is 94% less than the comparable oral diclofenac treatment.

"Voltaren Gel is proven to be effective for osteoarthritis of the hand and knee and has a favorable safety profile. The combination of benefit and safety provides a welcome new treatment approach for osteoarthritis, offering patients an alternative to oral therapies," said Roy Altman, MD, Professor of Medicine in the Division of Rheumatology and Immunology at UCLA in Los Angeles and Past President of the Osteoarthritis Research Society International. "Voltaren Gel delivers the proven efficacy of diclofenac with significantly less systemic absorption, minimizing the risk of side effects."

The efficacy and safety of Voltaren Gel were studied in more than 900 patients with knee or hand osteoarthritis. The US approval was based on several studies, including the results of two randomized, double-blind, placebo-controlled efficacy studies and a 12-month safety study.

Voltaren Gel was shown to significantly reduce pain in hand and knee osteoarthritis, with pain relief sustained through the end of treatment. After six weeks of treatment in an efficacy study of patients with osteoarthritis of the hand, results showed that pain levels were reduced by nearly half (46%). In a 12-week study in patients with osteoarthritis of the knee, Voltaren Gel showed a 51% reduction in pain.

"Voltaren Gel represents an important clinical milestone - it is the first prescription topical treatment in the US shown to relieve osteoarthritis pain and to clinically prove efficacy in treating both the knees and hands," said Jorge Insuasty, MD, Senior Vice President, Research and Development, Novartis Consumer Health, Inc. "Patients now have the option to effectively treat osteoarthritis pain directly at the source with favorable tolerability."

Approximately 21 million people in the US have osteoarthritis,1 and the aging population in the US means 72 million more will be at risk for developing the condition by 2030.2 Osteoarthritis is a chronic, painful condition that often leads to working limitations and reduced overall health.3

About osteoarthritis

Osteoarthritis is a chronic condition characterized by the breakdown of cartilage in the joint. Cartilage cushions the ends of the bones in joints - such as knees, hands, elbows, wrists, ankles and feet - which allows for easy movement. When cartilage erodes, bones can rub together, resulting in pain and loss of free movement in the joint.3 The most common symptoms include pain, joint soreness, stiffness and deterioration of overall coordination, posture and walking.

Arthritis and related conditions, such as osteoarthritis, cost the US economy nearly $128 billion per year in medical care and indirect expenses, including lost wages and production.4

Despite the high prevalence of osteoarthritis, there is no cure for this disease, which tends to progressively reduce mobility and the overall health state in the affected patients.

About Voltaren Gel

Voltaren Gel provides 1% diclofenac sodium in a topical gel formulation. It is a non-steroidal anti-inflammatory (NSAID) medication indicated for the pain of osteoarthritis in joints amenable to topical treatment, such as the knees and those of the hands. Voltaren Gel delivers highly effective pain relief with a favorable safety profile as its systemic absorption is 94% less than comparable oral diclofenac treatment.

Important safety information

The most common adverse reactions reported in Voltaren Gel clinical trials were application site reactions in 7% of treated patients. With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.

The use of Voltaren Gel is contraindicated in patients with a known hypersensitivity to diclofenac.

Voltaren Gel should not be administered to patients who have experienced asthma, urticaria or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.

Voltaren Gel is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.

Voltaren Gel joins other available Voltaren prescription medications in the US as well as the Novartis global portfolio of Voltaren Emulgel products. For full prescribing information, visit www.voltarengel.com or call 1-800-452-0051.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "will," "often leads to," "may be," "can be," or similar expressions, or by express or implied discussions regarding potential future revenues from Voltaren Gel. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Voltaren Gel will achieve any particular levels of revenue in the future. In particular, management's expectations regarding commercialization of Voltaren Gel could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data, competition in general, increased government, industry and general public pricing pressures, unexpected regulatory actions or delays or government regulation generally, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the U.S. Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit our website at http://www.novartis.com

References

1 U.S. Centers for Disease Control and Prevention (CDC). Arthritis Related Statistics. Available at: http://www.cdc.gov/arthritis/data_statistics/arthritis_related_statistics.htm Accessed on October 17, 2007.

2 National Institute of Arthritis Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health, U.S. Department of Health and Human Services. Handout on Health: Osteoarthritis. Available at: http://www.niams.nih.gov/health_info/Osteoarthritis/default.asp Accessed on October 17, 2007.

3 Arthritis Foundation. Available at: www.arthritis.org. Accessed on October 17, 2007.

4 U.S. Centers for Disease Control and Prevention (CDC). [CDC (2007) Update: National and State Medical Expenditures and Lost Earnings Attributable to Arthritis and Other Rheumatic Conditions--United States, 2003. MMWR Morb Mortal Wkly Rep, 56(01):4-7.

###

Other Article Sites

findabook.com  moneycd.info  a-mortgage.info   about-lemon-laws.info  aboutstudentloans.info
all-about-publishing.info  auctions-articles.info  bestcollege-university.com  bestispconnection.com
biblefolder.com  blogger-website.com  books-used.info  brokers-guide.info  buywindows.info  cable-dsl.info
career-miner.com  carpel-tunnel.info  cashinaflash.info  cashloanreviews.info  casinobell.com  chat-house.info
clearmycredit.info  collegeloantips.info  crones.info  depression-articles.info   dirnic.net  dishguides.info
divers-below.com  expodog.info   financewizz.com  fire-insurance.info  getgood.info  handleit.net   it-idea.info
health-supplies.info  hosting-right.com  insidealert.com  insurance-facts.info  jobs-employment.info
justgood.info  lookgold.net   lowcost-travel.info  money-source.info  myhostzone.info  numisblog.com
peoplesearchfinder.info  pr-articles.info  realeas.com   refinancing-guides.info  spyware-remove.info
telelot.info  the-law.info   toppaid.info  travel-deals.info  travelcorrect.com  wedding-guide-site.com
your-blog.info  your-credit.info

MORE ARTICLES:

Biofeedback Pain Relief Device First of its Kind to be Registered with FDA
ONDAMED® is a FDA registered Class II biofeedback device and currently an IRB approved status as a secondary therapeutic device for the treatment of various disorders which alleviates pain, discomfort, or general malaise. The device is now awaiting final designation as a pain-treatment device.

Why Pain?: An Understanding of Pain as a Necessary Part of Personal Growth
Champions expect pain, endure pain, and never complain. ---UnknownAfter so many years of studying personal development and thinking that the change I was looking for is going to come from that new book or new audio program, I realized that I was mistaken.

Hip Arthritis - Pain Relief
Hip arthritis is without doubt one of the most common forms of arthritis- which can have many different causes. There is one factor in common however- this is loss of cartilage from the hip joint. The loss of cartilage results in the hip bones grinding unnaturally together, resulting in pain. Hip arthritis advances quite quickly once it sets in, and pain and treatment options vary greatly depending on the patient?s age, health and lifestyle.

Colorado Cosmetic Surgeons Provides Clients With The Latest Technology In Pain Relief For Post-Surgical Recovery
In a recent Harris Interactive nationwide survey, over 47% of women surveyed stated they had a fear of post-operative pain. One Colorado cosmetic surgery center is offering a solution for dealing with post-operative pain, and minimizing its effects for quick recoveries for surgeries such as abdominoplasty (tummy tucks) and breast augmentation.

Hypnosis As A Management for Pain
Pain is defined as an unpleasant sensation ranging from slight, localized soreness to misery. This feeling features both physiological and psychological elements. It frequently results in a lack of enthusiasm and energy. These individuals experience exhaustion and psychologically stressed. This sensation can create difficulties with professional, private, and personal interactions.

Physicians, Chiropractors and Physical Therapist Agree on a New Treatment for Low Back Pain
One of the most prevalent and difficult health conditions to treat in the physical medicine is low back pain. The difficulty in treating low back pain comes from the fact that there are numerous causes including herniated discs, bulging discs, degenerative discs, muscle spasms, facet arthritis, and sciatica.

Eight Out Of 10 Americans Will Suffer From Lower Back Pain; Heartland Rehabilitation Services Heals with Hands-on Physical Therapy
Some 80 percent of the population will experience lower back pain at some point in their lives, a figure that is reaching epidemic proportions. For many people, lower back pain will come in the form of a back strain or sprain. Treatment may be as simple as a few trips to a physical therapist, an avenue most people don't consider, according to Heartland Rehabilitation Services.

New Clinical Trial Announced for Break through Cancer Pain
Exodon announces a new clinical research trial to combat break through cancer pain. The focus of the campaign is to study the efficacy of a new nasal spray.

Addressing The Cause And Finding A Cure: Why Cause is Everything When It Comes To Low Back Pain
There is an epidemic, at least in the States when it comes to treating back pain. Most doctors do just that.

Have Stronger Bones By In Taking More Calcium Vitamin
There are many advantages of an increased intake of calcium vitamin Calcium can not only protect from osteoporosis by building healthy bones

Pain on top of the foot
The purpose of this article is to give you information seekers an easier way to diagnose your pain on the top of the foot. I have noticed that many people use "top of foot pain" as their "search" term.

Back Pain Ruining Sex Lives
New survey reveals back pain results in less sex, less satisfying sex, and more relational difficulties.

Arthritis Pain Relief : Questions To Ask Your Healthcare Provider
A great place to begin taking charge of you arthritis pain relief and prevention planning is by making an appointment with your healthcare provider and finding out more about your condition and treatment options.Make sure to jot down questions ahead of time, and take them along in your journal or notebook, armed with a pencil to fill in his or her replies.

The Pain Of Motor Vehicle Accident Injury
Accidents have become so common these days. Most people who drive a car or vehicle would have at least experienced one accident in their lives. We are all aware that thousands of people die due to motor vehicle accidents on the roads, some due to the rash and negligent driving of insensitive drivers and others due to some freak accident. It is always useful for everyone to know some important information regarding motor vehicle accident injury and what exactly you should do in the particular circumstances.If at anytime you are involved in a car accident, make sure that you receive immediate medical attention for any injuries you might have sustained on your person. If you find that you are injured seriously, get someone closest to you to ca...